Managing Chronic Heart Failure in Special Populations

This activity will address the management of heart failure (HF) in older adults, African Americans, patients with diabetes, and patients with poor renal function.
Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA
Robert L. Page II, PharmD, MSPH, BCPS (AQ-Cards), BCGP, FCCP, FASHP, FAHA, FHFSA
Released: May 24, 2019

Information on this Educational Activity

Faculty

Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA

Professor of Medicine
The Mary and Gordon Cain Chair & W.A. "Tex" and Deborah Moncrief, Jr., Chair
Vice-Chair of Department of Medicine Baylor College of Medicine
Associate Director, Cardiovascular Research Institute
Director, Winters Center for Heart Failure Research
Baylor College of Medicine 
Houston, Texas

Dr. Bozkurt discloses the following: Consultant: Bristol-Myers Squibb, scPharmaceuticals, Inc., Lantheus Medical Imaging, Bayer HealthCare Pharmaceuticals, Respicardia, Abbott Vascular, Anthem, LivaNova
Robert L. Page II, PharmD, MSPH, BCPS (AQ-Cards), BCGP, FCCP, FASHP, FAHA, FHFSA

Professor, Department of Clinical Pharmacy
Clinical Specialist, Division of Cardiology
University of Colorado Anschutz Medical Campus
Aurora, Colorado

Dr. Page has no relevant conflicts of interest to disclose.

Target Audience

Cardiologists, internists, pharmacists, NPs, PAs and other clinicians who encounter patients with HF.

Program Medium

This program has been made available online.

Related Content

Expert commentary on updates to the 2022 AHA/ACC/HFSA heart failure guidelines, from Clinical Care Options (CCO)

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 10, 2022 Expired: May 9, 2023

Clinical Care Options (CCO): Expert commentary covering new data in HFpEF diagnosis and treatment from ACC 2022 Annual Scientific Sessions

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: April 26, 2022 Expired: April 25, 2023

Clinical Care Options (CCO): Expert commentary covering new data in HFrEF management from ACC 2022, including SODIUM-HF, PROMPT-HF, DIAMOND, and EMPULSE

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: April 20, 2022 Expired: April 19, 2023

From ACC 2022, exploratory analysis of renal outcomes with sacubitril/valsartan vs valsartan in HFpEF with and without diabetes in PARAGON-HF trial as reported by Clinical Care Options (CCO)

Released: April 6, 2022
Provided by Purdue University
Purdue University Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings